NORCROSS, Ga., Oct. 10, 2013 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics, today announced that it will hold a conference call with debt investors on Thursday, October 17 at 11:00 a.m. ET to discuss its fiscal 2014 first quarter results.
Interested debt investors and analysts should contact Immucor Investor Relations at investor-requests@immucor.com or 770-441-2051 for details.
About Immucor
Founded in 1982, Immucor manufactures and sells a complete line of reagents and systems used by hospitals, reference laboratories and donor centers to detect and identify certain properties of the cell and serum components of blood prior to transfusion. Immucor markets a complete family of automated instrumentation for all of its market segments. With its March 2013 acquisition of LIFECODES, Immucor entered transplantation diagnostics. For more information on Immucor, please visit our website at www.immucor.com.